Latest: Purigen Biosystems gets CE mark for nucleic acid isolation system
Latest: How serology testing could impact SARS-CoV-2 vaccine delivery
Latest: Advancing oncology therapeutics development with 2D & 3D cell screening
Latest: Agilent has announced the 8697 Headspace Sampler with integrated intelligence
Latest: Speed up multiresidue pesticides analysis with low-pressure GC-MS
Latest: Win big with SelectScience by sharing your opinion on laboratory products!
Latest: New Rigaku handheld LIBS analyzer provides high-performance metal alloy analysis
Overcome electrolyte analysis challenges with maintenance-free biosensor technology
Safeguarding public health against antimicrobial-resistant bacteria
Purigen Biosystems gets CE mark for nucleic acid isolation system
Speeding up cell culture workflows with INTEGRA’s serological pipettor
How serology testing could impact SARS-CoV-2 vaccine delivery
Advancing oncology therapeutics development with 2D & 3D cell screening
Increasing LC-MS accessibility for streamlined biotherapeutic analysis
The essential guide to ELISA automation
VisioNize Lab Suite
Preventing problems to achieve optimal analysis
Battling COVID-19: A new model of cytokine release syndrome
Novel antibody tests reveal complexity of immune response to COVID-19
DNA/RNA Purification and Analysis
Pre-Clinical and Clinical Automation
Cell Counting Technology
Cell Analysis Microscopy Equipment
Virtual Cancer & Immunology Research Summit
SelectScience Virtual Summit...
11 May 21 - 12 May 21
21 May 21 - 25 May 21
07 Jun 21 - 11 Jun 21
22 Jun 21 - 23 Jun 21
SLAS Europe 2021
22 Jun 21 - 25 Jun 21
LGC has established itself as a world-class leader in biopharmaceutical drug development through analytical excellence with over 200 scientists across three UK facilities. Read more...
As regulatory pressure increases on pharmaceutical companies to investigate the potential interaction between a dosage form and the components of the primary closure and transfer system employed, leachables and extractables studies are be... Read more...
LGC is highly experienced in the application of a broad range of material characterisation techniques and packages and has the knowledge to support your product development from discovery to product registration and beyond. Read more...
Within the pharmaceutical sector, there is an increasing regulatory requirement for the characterisation and counting of visible and sub-visible foreign particles in pharmaceutical products from a safety, quality and efficacy perspective. Read more...
Bringing together Axolabs, Biosearch Technologies and the broader analytical and bioanalytical capabilities available across the company, LGC has a unique heritage and expertise in the development oligonucleotide therapeutics and nucleic ... Read more...